Pure Global
NCT06032650

Calisthenics Versus High Intensity Interval Training in NAFL

Calisthenics Versus High-intensity Interval Exercises on Health-related Outcomes in Patients With Non-alcoholic Fatty Liver
Cairo University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Non-Alcoholic Fatty Liver Disease
Drug/Device/Intervention
Calisthenics exercise and High intensity interval training
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Cairo University
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Nov 01, 2024
Enrollment
60 participants
Primary outcome

Liver ultrasound parameters,Blood lipid profile

Summary

According to sample size calculation and after achieving the inclusion criteria, sixty
 patients with non-alcoholic fatty liver (NAFL) of both genders will be enrolled in this study
 and their ages will be ranged from30s-40s; they will be selected from internal
 medicine-outpatient clinics, Cairo University Hospitals; they will participate in the study
 for 8 weeks, and randomly be assigned into two equal groups in number.
 
 Group (A) (n =30) will receive calisthenics exercise three times /week for eight weeks, group
 (B) (n =30) will receive HIIT for three times /week for eight weeks and all patients in both
 groups will receive their prescribed medication (Statin 5mg ).

ICD-10 classifications
Alcoholic fatty liverAlcoholic liver disease, unspecifiedAlcoholic liver diseaseLiver disease, unspecifiedAlcoholic cirrhosis of liver
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06032650
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06032650 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Not yet recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.